As reported in the Wall Street Journal, the global pharmaceutical company Pfizer have remained the world’s largest drug company based on sales in 2009.
1st Place: Pfizer
- 2009 saw a major reshuffle of the top 15 players in the pharmaceutical industry. Pfizer’s $68 billion acquisition of Wyeth helped the pharmaceutical company to rank highly by generating sales of approximately $57.02 billion in 2009, up from $43.3 billion in the year earlier as a stand-alone firm.
2nd Place: Merck & Co
- As a result, Pfizer generated 46.6% more in annual revenue than its closest rival Merck & Co. Merck’s $41million buy out of Schering-Plough catapulted the U.S. pharmaceutical company to second place in the rankings.
3rd Place: Novartis
- The Swiss pharmaceutical giant, Novartis, generated revenues of $38.46 billion in 2009.
4th Place: GlaxoSmithKline
- GSK remained on the sidelines during last years reshuffle and has lost their second place position, now ranking fifth, one place behind France-based Sanofi-Aventis.
Pharmaceutical companies such as AstraZeneca Plc, Switzerland-based Roche Holding, Johnson & Johnson, Eli Lilly & Co and Abbott Laboratories held on to their positions among the world’s ten largest pharma companies at the end of 2009.
Analysts believe that the consolidation will continue throughout 2010 has pharmaceutical companies make steps to react to slow growth rates in industrialised counties, cost cutting my governments and increased competition from generic drug makers. For example, the Israel-based Teva Pharmaceutical Industries could soon become a top player should the vision of Chief Executive Shlomo Yanai to double sales to $31 billion by 2015 materialise.
Looking for a job in the pharmaceutical industry? Click here to search our pharmaceutical job vacancies now.